UBS Group’s Titan Pharmaceuticals TTNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4K | Buy |
3,427
+833
|
|
||||
|
2025
Q1 | $9.16K | Sell |
2,594
-73
|
|
||||
|
2024
Q4 | $8.69K | Sell |
2,667
-2,106
|
|
||||
|
2024
Q3 | $25.2K | Buy |
4,773
+4,772
|
|
||||
|
2024
Q2 | $6 | Hold |
1
|
|
||||
|
2024
Q1 | $7 | Buy |
+1
|
|
||||
|
2023
Q4 | – | Hold |
0
|
|
||||
|
2023
Q3 | – | Hold |
0
|
|
||||
|
2023
Q2 | – | Sell |
-76
|
|
||||
|
2023
Q1 | $1.27K | Buy |
76
+68
|
|
||||
|
2022
Q4 | $129 | Sell |
8
-551
|
|
||||
|
2022
Q3 | $12K | Sell |
559
-788
|
|
||||
|
2022
Q2 | $15K | Buy |
1,347
+991
|
|
||||
|
2022
Q1 | $7K | Buy |
356
+166
|
|
||||
|
2021
Q4 | $4K | Sell |
190
-165
|
|
||||
|
2021
Q3 | $13K | Sell |
355
-59
|
|
||||
|
2021
Q2 | $22K | Sell |
414
-759
|
|
||||
|
2021
Q1 | $70K | Buy |
1,173
+870
|
|
||||
|
2020
Q4 | $20K | Buy |
303
+297
|
|
||||
|
2020
Q3 | $1K | Sell |
6
-188
|
|
||||
|
2020
Q2 | $36K | Buy |
194
+68
|
|
||||
|
2020
Q1 | $18K | Buy |
126
+55
|
|
||||
|
2019
Q4 | $8K | Buy |
71
+69
|
|
||||
|
2019
Q3 | $0 | Sell |
2
-1
|
|
||||
|
2019
Q2 | $2K | Sell |
3
-10
|
|
||||
|
2019
Q1 | $14K | Buy |
13
+8
|
|
||||
|
2018
Q4 | $4K | Buy |
5
+4
|
|
||||
|
2018
Q3 | $1K | Buy |
+1
|
|
||||
|
2018
Q2 | – | Sell |
-1
|
|
||||
|
2018
Q1 | $2K | Buy |
+1
|
|
||||
|
2017
Q4 | – | Sell |
-1
|
|
||||
|
2017
Q3 | $8K | Hold |
1
|
|
||||
|
2017
Q2 | $4K | Buy |
+1
|
|
||||
|
2017
Q1 | – | Sell |
-1
|
|
||||
|
2016
Q4 | $13K | Hold |
1
|
|
||||
|
2016
Q3 | $11K | Buy |
+1
|
|
||||
|
2016
Q2 | – | Hold |
0
|
|
||||
|
2016
Q1 | – | Hold |
0
|
|
||||
|
2015
Q4 | – | Hold |
0
|
|